• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ALSFRS-R.

作者信息

Gordon Paul H, Miller Robert G, Moore Dan H

机构信息

Eleanor and Lou Gehrig MDA/ALS Research Center, Neurological Institute, New York, NY 10032, USA.

出版信息

Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:90-3. doi: 10.1080/17434470410019906.

DOI:10.1080/17434470410019906
PMID:15512883
Abstract

The ALSFRS-R is an attractive primary outcome measure in clinical trials of ALS because it is validated, easy to administer, minimizes dropout, reduces cost, and correlates with survival. Unlike the other standard outcome measures currently employed, the ALSFRS-R is also a measure of global function.

摘要

相似文献

1
ALSFRS-R.
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:90-3. doi: 10.1080/17434470410019906.
2
Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial.在一项多中心临床试验中，肌萎缩侧索硬化功能评定量表修订版（ALSFRS-R）具有出色的评分者间、评分者内及电话施测信度。
Amyotroph Lateral Scler. 2007 Feb;8(1):42-6. doi: 10.1080/17482960600888156.
3
The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.肌萎缩侧索硬化功能评定量表。肌萎缩侧索硬化患者日常生活活动能力评估。肌萎缩侧索硬化睫状神经营养因子治疗研究（ACTS）I-II期研究组。
Arch Neurol. 1996 Feb;53(2):141-7.
4
[Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].肌萎缩侧索硬化功能评定量表的研究：修订版肌萎缩侧索硬化功能评定量表（ALSFRS-R）日语版
No To Shinkei. 2001 Apr;53(4):346-55.
5
Outcome measures for early phase clinical trials.早期临床试验的结果指标。
Amyotroph Lateral Scler. 2007 Oct;8(5):270-3. doi: 10.1080/17482960701547958.
6
[Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study].[使用肌萎缩侧索硬化功能评定量表修订版（日语版）开发肌萎缩侧索硬化患者电话调查系统及其在纵向多中心研究中的应用]
Brain Nerve. 2011 May;63(5):491-6.
7
Non-self-sufficiency as a primary outcome measure in ALS trials.在肌萎缩侧索硬化症试验中，将无法自理作为主要结局指标。
Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):77-84. doi: 10.3109/21678421.2015.1074704. Epub 2015 Oct 16.
8
Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R.护理人员通过电话使用肌萎缩侧索硬化功能评定量表修订版（ALSFRS-R）对肌萎缩侧索硬化症的严重程度进行评级。
Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Mar;6(1):50-4. doi: 10.1080/14660820510027107.
9
Clinical significance in the change of decline in ALSFRS-R.肌萎缩侧索硬化功能评分量表修订版（ALSFRS-R）下降变化的临床意义。
Amyotroph Lateral Scler. 2010;11(1-2):178-80. doi: 10.3109/17482960903093710.
10
ALSFRS and appel ALS scores: discordance with disease progression.肌萎缩侧索硬化功能评分量表（ALSFRS）和阿佩尔肌萎缩侧索硬化评分：与疾病进展不一致。
Muscle Nerve. 2008 May;37(5):668-72. doi: 10.1002/mus.20977.

引用本文的文献

1
Impact of SOD1 Transcript Variants on Amyotrophic Lateral Sclerosis Severity.超氧化物歧化酶1（SOD1）转录变体对肌萎缩侧索硬化症严重程度的影响。
Int J Mol Sci. 2025 Jul 15;26(14):6788. doi: 10.3390/ijms26146788.
2
Home-Based Tele-tDCS in Amyotrophic Lateral Sclerosis: Feasibility, Safety, and Preliminary Efficacy.肌萎缩侧索硬化症的家庭式远程经颅直流电刺激：可行性、安全性及初步疗效
Ann Clin Transl Neurol. 2025 May;12(5):1022-1033. doi: 10.1002/acn3.70038. Epub 2025 Mar 24.
3
Reliability and consistency of the Japanese version of the Primary Lateral Sclerosis Functional Rating Scale.
原发性侧索硬化功能评定量表日语版的信度和一致性。
BMC Neurol. 2024 Aug 13;24(1):282. doi: 10.1186/s12883-024-03729-6.
4
Accelerating drug development for amyotrophic lateral sclerosis: construction and application of a disease course model using historical placebo group data.加速肌萎缩侧索硬化症药物研发：利用历史安慰剂组数据构建和应用疾病进程模型。
Orphanet J Rare Dis. 2024 Feb 2;19(1):40. doi: 10.1186/s13023-024-03057-5.
5
Randomized double-blind personalized N-of-1 clinical trial to test the safety and potential efficacy of TJ-68 for treating muscle cramps in amyotrophic lateral sclerosis (ALS): study protocol for a TJ-68 trial.随机双盲个体化 N-of-1 临床试验，以测试 TJ-68 治疗肌萎缩侧索硬化症（ALS）肌肉痉挛的安全性和潜在疗效：TJ-68 试验研究方案。
Trials. 2023 Jul 10;24(1):449. doi: 10.1186/s13063-023-07424-8.
6
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment.维生素 D 水平在肌萎缩侧索硬化症认知障碍中的潜在作用。
Neurol Sci. 2023 Aug;44(8):2795-2802. doi: 10.1007/s10072-023-06751-7. Epub 2023 Mar 23.
7
A meta-analysis of post-exercise outcomes in people with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者运动后结果的荟萃分析。
eNeurologicalSci. 2023 Feb 21;31:100452. doi: 10.1016/j.ensci.2023.100452. eCollection 2023 Jun.
8
ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale.修订版肌萎缩侧索硬化功能评定量表适应性、注释性及自解释性版本（ALSFRS-R-SE）
Neurol Res Pract. 2022 Dec 15;4(1):60. doi: 10.1186/s42466-022-00224-6.
9
Analysis of routine blood parameters in patients with amyotrophic lateral sclerosis and evaluation of a possible correlation with disease progression-a multicenter study.肌萎缩侧索硬化症患者常规血液参数分析及与疾病进展可能相关性的评估——一项多中心研究
Front Neurol. 2022 Jul 27;13:940375. doi: 10.3389/fneur.2022.940375. eCollection 2022.
10
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients.肌萎缩侧索硬化症患者营养咨询的远程医疗干预措施。
J Clin Med. 2022 Jul 23;11(15):4286. doi: 10.3390/jcm11154286.